PTCT
#1240
PTC Therapeutics, Inc. - Common Stock
69.1 6 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.33%
Changement Mensuel
+2.95%
Evolution sur 6 mois
+3.10%
Changement Annuel
+39.80%
Clôture Précédente
70.0 9
Open
69.3 4
Low
68.8 6
High
69.5 8
Volume
212
Financials
- Market Capitalization 5.77 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-151.06
ratio cours/chiffre d'affaires
7.09
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1225 |  BLTE Belite Bio Inc - American Depositary Shares | 152.21 USD | +0.32% | -4.47% | -3.40% | +144.79% | 5.99 B USD | ||
| 1232 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 103.58 USD | -2.14% | -5.77% | -1.95% | +342.84% | 5.79 B USD | ||
| 1248 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.42 USD | -0.95% | -2.29% | -6.00% | +45.67% | 5.75 B USD | ||
| 1276 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 277.79 USD | -0.96% | -1.96% | -3.26% | +48.46% | 5.54 B USD |